Abstract
In pulmonary hypertension, systemic infusion of adrenomedullin (ADM), a potent vasodilator peptide, leads to pulmonary vasodilatation. However, systemic blood pressure declines alike. The present study investigated the effect of aerosolized ADM on pulmonary arterial pressure in surfactant-depleted newborn piglets with pulmonary hypertension. Animals randomly received aerosolized ADM (ADM, n = 6), aerosolized ADM combined with intravenous application of NG-nitro-l-arginine methylester to inhibit nitric-oxide (NO) synthases (ADM + l-NAME, n = 5), or aerosolized normal saline solution (control, n = 6). Aerosol therapy was performed in 30-min intervals for 5 h. After a total experimental period of 8 h, mRNA expression of endothelial and inducible NO synthase and endothelin-1 (ET-1) in lung tissue was quantified using TaqMan real-time polymerase chain reaction. Aerosolized ADM reduced mean pulmonary artery pressure (MPAP) compared with control (p < 0.001; at the end of the study, Δ-MPAP -13.5 ± 1.4 versus -6.2 ± 2.4 mm Hg). PaO2 significantly increased in the ADM (ΔPaO2 243.3 mm Hg) and the ADM + l-NAME group (ΔPaO2 217.4 mm Hg) compared with the control group (ΔPaO2 82.9 mm Hg; p < 0.001). Aerosolized ADM did not influence mean systemic arterial pressure (baseline 63.2 ± 2.7 versus end of the study 66.3 ± 6.5 mm Hg; not significant). NO synthases gene expressions were 20 to 30% lower with ADM compared with control. ET-1 gene expression was significantly reduced (>50%) after ADM aerosol therapy (p < 0.001). Aerosolized adrenomedullin significantly reduced MPAP without lowering the systemic arterial pressure and improved profoundly the arterial oxygen tension. This effect seems to be mediated at least in part by the reduction of ET-1.
Footnotes
-
↵1 These authors contributed equally to this work.
-
The study was supported by grant of the center for interdisciplinary clinical research (Interdisziplinäres Zentrum für Klinische Forschung) (University of Erlangen-Nuernberg, Germany).
-
Article, publication date, and citation information can be found at http://jpet.aspetjournals.org.
-
DOI: 10.1124/jpet.103.049817.
-
ABBREVIATIONS: ET-1, endothelin-1; ADM, adrenomedullin; l-NAME, NG-nitro-l-arginine methylester; NO, nitric oxide; PCR, polymerase chain reaction; HPRT, hypoxanthine-guanine-phosphoribosyl-transferase; ANOVA, analysis of variance; MPAP mean pulmonary artery pressure; MAP, mean arterial pressure; iNOS, inducible nitric-oxide synthase; eNOS, endothelial nitric-oxide synthase; bp, base pairs.
- Received January 30, 2003.
- Accepted May 8, 2003.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|